Contatta
la direzione medica.
Per informazioni o approfondimenti, è possibile contattare la Direzione Medica di Roche Italia
CONTATTA
Bibliografia
- WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
- Wu F et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798): 265-9. https://pubmed.ncbi.nlm.nih.gov/32015508/
- Zhou P et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270-3. https://doi.org/10.1038/s41586-020-2012-7/
- Bloom JD et al. Investigate the origins of COVID-19. Science 2021; 372(6543): 694. www.who.int/publications/i/
- Our World in Data. Coronavirus (COVID-19) Cases - Statistics and Research. https://ourworldindata.org/covid-cases
- Ministero della Salute. Che cos’è il nuovo coronavirus. https://www.salute.gov.it/portale/nuovocoronavirus/dettaglioFaqNuovoCoronavirus.jsp? lingua=italiano&id=257#3
- Latest evidence on COVID-19 - ECD - Europe. www.ecdc.europa.eu/en/covid-19/latest-evidence
- Lauer SA et al. The incubation period of coronavirus disease 2019 (CoVID-19) from publicly reported confirmed cases: Estimation and application. Ann Int Med 2020;172(9): 577-82. https://pubmed.ncbi.nlm.nih.gov/32150748/
- McAloon C et al. Incubation period of COVID-19: A rapid systematic review and meta-analysis of observational research. BMJ Open 2020; 10: e039652. https://pubmed.ncbi.nlm.nih.gov/32801208/
- Guan W et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Eng J Med 2020; 382(18): 1708-20. https://pubmed.ncbi.nlm.nih.gov/32109013/
- WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), 2020 https://www.who.int/docs/defaultsource/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
- National Institute of Infectious Diseases, Japan. Field Briefing: Diamond Princess COVID-19 Cases, 20 Feb Update. https://www.niid.go.jp/niid/en/2019-ncov-e/9417-covid-dp-fe-02.html
- Istituto Superiore di Sanità. Sorveglianza Integrata COVID-19 in Italia – 27 febbraio, 2020 https://www.iss.it/documents/20126/0/Infografica_09marzo.pdf
- Huang R et al. A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China. Lancet Infect Dis 2020; 20: 534-5. https://www.who.int/china/news/
- Long QX et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Med 2020; 26(8): 1200-4. https://pubmed.ncbi.nlm.nih.gov/32555424/
- Hu Z et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci 2020; 63(5): 706-11. https://pubmed.ncbi.nlm.nih.gov/32146694/
- WHO. Q&A on COVID-19 and related topics. https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19
- Therapeutics and COVID-19: living guideline - World Health Organization (WHO), 6 July 2021 https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2021.2
- Galanti M et al. Longitudinal active sampling for respiratory viral infections across age groups. Influenza Other Respir Viruses 2019; 13(3): 226-32. https://pubmed.ncbi.nlm.nih.gov/30770641/
- Killerby ME et al. Human coronavirus circulation in the United States 2014–2017. J Clin Virol 2018; 101: 52-6. https://pubmed.ncbi.nlm.nih.gov/29427907/
- Paules CI et al. Coronavirus Infections-more than just the common cold. JAMA 2020; 323: 707-8. https://jamanetwork.com/
- Centers for Disease Control and Prevention. SARS-CoV-2 Variant Classifications and Definitions (updated July 20, 2021). https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html
- Wrapp D et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. bioRxiv 2020; 2020.02.11.9444462. http://www.ncbi.nlm.nih.gov/pubmed/32511295
- Callaway E. Making sense of coronavirus mutations. Nature 2020; 585: 174-7. http://www.nature.com/articles/d41586-020-02544-6
- GISAID – Initiative. https://www.gisaid.org/
- Van Dorp L et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol 2020; 83: 104351 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199730/
- Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health. https://www.who.int/publications/i/item/9789240018440
- De Angelis G et al. Le varianti di SARS-CoV-2. GImPIOS gennaio-marzo 2021; 11(1): 44-46. https://www.gimpios.it/r.php?v=3614&a=35954&l=344821&f=allegati/03614_2021_01/fulltext/08_DeAngelis.pdf
- ISS, Fondazione Bruno Kessler, Ministero della Salute. Stima della prevalenza delle varianti VOC (Variants of Concern) in Italia: B.1.1.7, B.1.351, P.1 e B.1.617.2, e altre varianti di SARS-CoV-2, 30 luglio 2021. https://www.quotidianosanita.it/allegati/allegato3972087.pdf
M-IT-00000976